Lebenthal Holdings’s Regeneron Pharmaceuticals REGN Stock Holding History

Lebenthal Holdings’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$691K	Sell	1,978 -2,799	-59%	-$1.08M	0.09%	230
2016 Q1	$1.73M	Buy	4,777 +622	+15%	+$256K	0.3%	124
2015 Q4	$2.25M	Sell	4,155 -2,369	-36%	-$1.28M	0.53%	61
2015 Q3	$3.03M	Buy	6,524 +1,539	+31%	+$826K	0.7%	35
2015 Q2	$2.59M	Sell	4,985 -329	-6%	-$161K	0.53%	58
2015 Q1	$2.4M	Buy	5,314 +4,601	+645%	+$1.95M	0.56%	62
2014 Q4	$292K	Buy	+713	New	+$280K	0.13%	167

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Lebenthal Holdings's REGN Position: Q2 2016 in Review

Lebenthal Holdings reduced its Regeneron Pharmaceuticals (REGN) stake by 59% in Q2 2016, selling an estimated $1.08M and leaving 1,978 shares worth $691K. The position accounts for 0.09% of the portfolio, ranked #230.

Lebenthal Holdings first reported a position in REGN in Q4 2014 and has held it in 7 quarters since. The position peaked at $3.03M in Q3 2015. 542 funds tracked by Wall St. Rank hold REGN as of Q2 2016.

Lebenthal Holdings held 1,978 shares of Regeneron Pharmaceuticals worth $691K as of Q2 2016.
Lebenthal Holdings sold 2,799 Regeneron Pharmaceuticals shares in Q2 2016, an estimated $1.08M.
Regeneron Pharmaceuticals made up 0.09% of Lebenthal Holdings's portfolio in Q2 2016, its #230 holding.
Lebenthal Holdings first reported a position in Regeneron Pharmaceuticals in Q4 2014 and has held it in 7 quarters since.
Lebenthal Holdings's Regeneron Pharmaceuticals position peaked at $3.03M in Q3 2015.
542 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2016.

Based on Lebenthal Holdings's 13F filing for Q2 2016, filed 19 Aug 2016.